Prostate cancer drug candidate funded by University City Science Center QED program
Could a compound developed by two University of Delaware faculty members be a new line of defense against prostate cancer? Robert Sikes, director of theCenter for Translational Cancer Research (CTCR) and associate professor ofbiological sciences, and John Koh, associate director of the Delaware Biotechnology Institute (DBI) and professor of chemistry and biochemistry, believe they have indeed invented a new […]